Evidence map›Paper›PMID 26639010›Full record

ArticleGenetic epidemiology2016

Meta-Analysis of Rare Variant Association Tests in Multiethnic Populations.

Akweley Mensah-Ablorh, Sara Lindstrom, Christopher A Haiman, Brian E Henderson, Loic Le Marchand, Seunngeun Lee, Daniel O Stram, A Heather Eliassen, Alkes Price, Peter Kraft

Abstract read
In one paragraph

Article in Genetic epidemiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Polymorphism rs1801516 (G > A) in theThe Journal of international medical research · 2020
    Pooled it
  2. Article
  3. Genome-wide Enrichment ofAmerican journal of respiratory and critical care medicine · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Akweley Mensah-AblorhDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Sara LindstromDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Christopher A HaimanDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, United States of America.
Brian E HendersonDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, United States of America.
Loic Le MarchandEpidemiology Program, University of Hawaii Cancer Research Center, Honolulu, Hawaii, United States of America.
Seunngeun LeeDepartment of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan, United States of America.
Daniel O StramDepartment of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, United States of America.
A Heather EliassenDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Alkes PriceDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Peter KraftDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America.

Funding

Risk Factors for Breast Cancer in Younger NursesR01CA050385 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI ELIASSEN, A. HEATHER, WILLETT, WALTER C. · 1989 to 2019
$32.3M
Life Course Cancer Epidemiology Cohort in WomenUM1CA176726 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2013 to 2017
$15.7M
Statistical methods for studies of rare variantsR01MH101244 · NIMH · HARVARD MEDICAL SCHOOL · PI Benjamin Michael Neale, ALKES L PRICE · 2013 to 2026
$9.4M
NCI NIH HHS R01 CA050385NIMH NIH HHS R01 MH101244
6 · The paper itself

Abstract

Several methods have been proposed to increase power in rare variant association testing by aggregating information from individual rare variants (MAF < 0.005). However, how to best combine rare variants across multiple ethnicities and the relative performance of designs using different ethnic sampling fractions remains unknown. In this study, we compare the performance of several statistical approaches for assessing rare variant associations across multiple ethnicities. We also explore how different ethnic sampling fractions perform, including single-ethnicity studies and studies that sample up to four ethnicities. We conducted simulations based on targeted sequencing data from 4,611 women in four ethnicities (African, European, Japanese American, and Latina). As with single-ethnicity studies, burden tests had greater power when all causal rare variants were deleterious, and variance component-based tests had greater power when some causal rare variants were deleterious and some were protective. Multiethnic studies had greater power than single-ethnicity studies at many loci, with inclusion of African Americans providing the largest impact. On average, studies including African Americans had as much as 20% greater power than equivalently sized studies without African Americans. This suggests that association studies between rare variants and complex disease should consider including subjects from multiple ethnicities, with preference given to genetically diverse groups.

Indexed as

Genetic VariationAsianBlack or African AmericanBlack PeopleBreast NeoplasmsCase-Control StudiesEthnicityFemaleHigh-Throughput Nucleotide SequencingHispanic or LatinoHumansModels, GeneticSequence Analysis, DNAWhite Peoplefine mappingmultiethnic meta-analysissequencing study designstatistical geneticsstudy subject selection

Identifiers

PMID26639010
PMCPMC4968883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.